Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Tg Therapeutics (TGTX) Shares Outstanding (Diluted Average) (2020 - 2023)

Historic Shares Outstanding (Diluted Average) for Tg Therapeutics (TGTX) over the last 4 years, with Q2 2023 value amounting to $141.5 million.

  • Tg Therapeutics' Shares Outstanding (Diluted Average) rose 498.88% to $141.5 million in Q2 2023 from the same period last year, while for Jun 2023 it was $141.5 million, marking a year-over-year increase of 498.88%. This contributed to the annual value of $135.4 million for FY2022, which is 241.15% up from last year.
  • Tg Therapeutics' Shares Outstanding (Diluted Average) amounted to $141.5 million in Q2 2023, which was up 498.88% from $140.3 million recorded in Q1 2023.
  • In the past 5 years, Tg Therapeutics' Shares Outstanding (Diluted Average) ranged from a high of $141.5 million in Q2 2023 and a low of $115.3 million during Q4 2020
  • Its 4-year average for Shares Outstanding (Diluted Average) is $133.2 million, with a median of $134.4 million in 2022.
  • In the last 5 years, Tg Therapeutics' Shares Outstanding (Diluted Average) surged by 1464.36% in 2021 and then soared by 189.68% in 2022.
  • Over the past 4 years, Tg Therapeutics' Shares Outstanding (Diluted Average) (Quarter) stood at $115.3 million in 2020, then grew by 14.64% to $132.2 million in 2021, then rose by 2.41% to $135.4 million in 2022, then grew by 4.5% to $141.5 million in 2023.
  • Its last three reported values are $141.5 million in Q2 2023, $140.3 million for Q1 2023, and $135.4 million during Q4 2022.